Dr. Ankita Nachankar

PhD- Heavy Ion Therapeutics and Engineering, Gunma University, Japan

DNB (Radiation Oncology), National Board of Examination, India

MD (Radiation Oncology) , Tata Memorial Hospital, India

MBBS (Medicine), Seth G.S. Medical College & KEM Hospital, India

Post-doctoral Researcher- Carbon-ion therapy- ACMIT Gmbh, and MedAustron

Radiation Oncology, Consultant, Sir H. N. Reliance Foundation Hospital, India

Radiation Oncology, Clinical Assistant, Sir H. N. Reliance Foundation Hospital, India

Radiation Oncology, Senior Residency, Tata Memorial Hospital, India

Member of AROI

Member of ESTRO

Member of PTCOG

Nachankar A, Schafasand M, Hug E, Martino G, Góra J, Carlino A, Stock M, Fossati P. Sacral-Nerve-Sparing Planning Strategy in Pelvic Sarcomas/Chordomas Treated with Carbon-Ion Radiotherapy. Cancers. 2024, 26;16:1284. (Impact factor –5.2)

Nachankar A, Fossati P. et al. Planning Strategy to Optimize the Dose-Averaged LET Distribution in Large Pelvic Sarcomas/Chordomas Treated with Carbon-Ion Radiotherapy. Cancers. 2023;15:4903. (Impact factor –5.2)

Nachankar A, Musha A, Kubo N, et al. Dosimetric analysis of intraocular hemorrhage in nonsquamous head and neck cancers treated with carbon-ion radiotherapy. Radiother Oncol. 2022;170:143-150. (Impact factor –6.28)

Nachankar, A.; Oike, T.; Hanaoka, H.; Kanai, A.; et al. 64Cu-ATSM Predicts Efficacy of Carbon Ion Radiotherapy Associated with Cellular Antioxidant Capacity. Cancers2021;13: 6159. (Impact factor –6.639)

Anakura M † , Nachankar A† , Kobayashi D, et al. Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses. Int J Mol Sci.2019;20:3635.(Impact factor –5.923)

Darwis NDM † , Nachankar A† , Sasaki Y, et al. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy. Int J Mol Sci. 2019;20:4563. (Impact factor –5.923)

Chen L, Platzer P, Reschl C, Schafasand M, Nachankar A, Lukas Hajdusich C, Kuess P, Stock M, Habraken S, Carlino A. Validation of a deep-learning segmentation model for adult and pediatric head and neck radiotherapy in different patient positions. Phys Imaging Radiat Oncol. 2023;29:100527

Schafasand M, Resch AF, Nachankar A, et al. Investigation on the physical dose filtered by linear energy transfer for treatment plan evaluation in carbon ion therapy. Medical Physics. 2023.

Mahantshetty U, Naga P, Nachankar A, et al. Set-Up Errors, Organ Motion, Tumour Regression and its Implications on Internal Target Volume-Planning Target Volume During Cervical Cancer Radiotherapy: Results From a Prospective Study. Clin Oncol (R Coll Radiol). 2021; 34:189-197.

Dessai S, Nachankar A, Kataria P, Abyankar A. Management of patients with gynecological cancers during the COVID-19 pandemic. Cancer Research, Statistics, and Treatment. 2020; 3:40.

Oike T, Komatsu S, Komatsu Y, Nachankar A, et al. Reporting of methodologies used for clonogenic assays to determine radiosensitivity. J Radiat Res. 2020; 61:828-31.

Rahul Krishnatry, Ankita A Nachankar, Tejpal Gupta,et al. Oral radiation mucositis: a short review. International Journal of Head and Neck Surgery.2011;2:37-43

Bajpai Jyoti, Chauhan Bharat, Nachankar Ankita, et al. Pregnancy on tamoxifen: Case-report and review of literature. South Asian J Cancer. 2016; 5: 209–210.

Ankita Nachankar, Rahul Krishnatry, Amit Joshi, et al. Primary mediastinal seminoma; resistance and relapse: an aggressive entity. Indian J Med PaediatrOncol2013;34:309-12.

Ankita Nachankar, Rahul Krishnatry, et al. Unusual coexistence of a renal anomaly and germ cell tumor: An embryonal happenstance? Indian J Med Paediatr Oncol. 2012; 33: 179–181.